Related Experiment Video

Updated: Jul 30, 2026

Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts
09:29

Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts

Published on: August 13, 2014

15.1K

ASO Author Reflections: Percutaneous Hepatic Perfusion: Past, Present, and Future

Jonathan S Zager1,2

  • 1Department of Cutaneous Oncology, Moffit Cancer Center, Tampa, FL, USA. jonathan.zager@moffitt.org.

Annals of Surgical Oncology
|April 29, 2024
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.4K
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.9K

Related Experiment Videos

Last Updated: Jul 30, 2026

Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts
09:29

Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts

Published on: August 13, 2014

15.1K
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.4K
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.9K

Related Concept Videos

Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...

Articles linked to this work by shared authors, journal, and citation graph.

Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trial.

Journal for immunotherapy of cancer·2026

Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.

Cancers·2026

Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative, or Not Performed Sentinel Lymph Node Biopsy.

Annals of surgical oncology·2025

Isolated Limb Infusion/Perfusion for Unresectable Acral Versus Non-Acral Melanoma In-Transit Metastases.

Annals of surgical oncology·2025

Isolated Limb Infusion or Perfusion as First-Line Versus Second-Line Therapy for In-Transit Metastatic Melanoma.

Annals of surgical oncology·2025

The Use of Radar-Guided Localization to Identify Metastatic Melanoma After Neoadjuvant Immunotherapy.

Annals of surgical oncology·2025

Three-Tiered Nodal Staging System Improves Prognostic Utility for Intrahepatic Cholangiocarcinoma.

Annals of surgical oncology·2026

Prophylactic Effects of Dietary Patterns and Indexes, Nutrition and Lifestyle on Hepatocellular Carcinoma.

Annals of surgical oncology·2026

Immune-Adjusted Nodal Risk Classification After Neoadjuvant Immunotherapy for Resectable Head and Neck Cutaneous Squamous Cell Carcinoma.

Annals of surgical oncology·2026

Missed Opportunities for Neoadjuvant Immunotherapy in Melanoma: Is it Time to Consider Ultrasound Staging for Newly Diagnosed Patients?

Annals of surgical oncology·2026

Oncological Outcomes of Segmentectomy for Centrally Located Small-Sized Non-small-cell Lung Cancer: A Multicenter Study (CReGYT-02 Study).

Annals of surgical oncology·2026

'They (researchers) don't have to justify their presence, why do we have to justify ours?': The political economy of community advisory boards in tuberculosis research.

Social science & medicine (1982)·2026

Measuring trust in public health authorities in the United States: An item response theory analysis.

PloS one·2026

Kidney Transplantation from Hepatitis C-Positive Donors in the Direct-Acting Antiviral Era.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026

Policy in implementation science: Considerations for measurement-based care in the Canadian Armed Forces.

Journal of military, veteran and family health·2026

Rigor is not readiness: The PERL framework for evidence-based policy.

Science (New York, N.Y.)·2026

Exploring Australian Health Promotion Practitioners' Awareness, Understanding and Application of Theories of the Policy Process in Health Promotion Practice: A Qualitative Study.

Health promotion perspectives·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us